| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |